(P-1276) Remdesivir and Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

JR

J. Lizbeth Reyes Zamora, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JL

Jiani Li, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
NP

Nadine Peinovich, MPH

Gilead Sciences, Inc.
Foster City, California, United States
CM

Clarissa Martinez, MPH

Gilead Sciences, Inc.
Foster City, California, United States
PH

Pui Yan Ho, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RM

Ross Martin, PhD

Sr Research Scientist II
Gilead Sciences
Foster City, California, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JP

Jason K. Perry, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States